Array

Vaccine development and manufacture today entail high costs, making some vaccines expensive. How are the Federal and State governments in the US financing immunizations so they can be available to the public?

The development of vaccine schedules and recommendations is a complex process. Here we answer some of the most common questions regarding indications, recommendations and laws for vaccine use.

When a vaccine is likely to be targeted to a limited number of individuals in the US—such as those suffering from a rare disease—it is called an “orphan vaccine”. Are there any orphan vaccines licensed in the US?

Public health officials often consider the expense and value of a healthcare intervention—such as a new vaccine—in terms of its value to society. That is, all costs and benefits, regardless as to who pays the costs and who obtains the benefit. This article explains how economic tools are applied to vaccines and immunizations.